EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations

Kristelle Hughes iD, Thanh Binh Le, Patrick Van Der Smissen, Donatienne Tyteca iD, Marie-Paule Mingeot-Leclercq iD, Joëlle Quetin-Leclercq iD

Molecules · 04.05.2023 · 28 (9) · 3871

DOI: 10.3390/molecules28093871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 04.05.2023. Verfasst von Kristelle Hughes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacognosy Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 72, B1.72.03, B-1200 Brussels, Bel…. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmaniasis, Leishmania mexicana. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vietnamese Ministry of Education and Training, UCL, F.S.R-FNRS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis is a neglected tropical disease that still infects thousands of people per year throughout the world. The occurrence of resistance against major treatments for this disease causes a healthcare burden in low-income countries. Eugenol is a phenylpropanoid that has shown in vitro antileishmanial activity against Leishmania mexicana mexicana (Lmm) promastigotes with an IC50 of 2.72 µg/mL and a high selectivity index. Its specific mechanism of action has yet to be studied. We prepared large unilamellar vesicles (LUVs), mimicking Lmm membranes, and observed that eugenol induced an increase in membrane permeability and a decrease in membrane fluidity at concentrations much higher than IC50. The effect of eugenol was similar to the current therapeutic antibiotic, amphotericin B, although the latter was effective at lower concentrations than eugenol. However, unlike amphotericin B, eugenol also affected the permeability of LUVs without sterol. Its effect on the membrane fluidity of Lmm showed that at high concentrations (≥22.5× IC50), eugenol increased membrane fluidity by 20–30%, while no effect was observed at lower concentrations. Furthermore, at concentrations below 10× IC50, a decrease in metabolic activity associated with the maintenance of membrane integrity revealed a leishmaniostatic effect after 24 h of incubation with Lmm promastigotes. While acidocalcisomes distribution and abundance revealed by Trypanosoma brucei vacuolar H+ pyrophosphatase (TbVP1) immunolabeling was not modified by eugenol, a dose-dependent decrease of lipid droplets assessed by the Nile Red assay was observed. We hereby demonstrate that the antileishmanial activity of eugenol might not directly involve plasma membrane sterols such as ergosterol, but rather target the lipid storage of Lmm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsLeishmaniasisLeishmania mexicanaHumansEugenolAmphotericin BSterols

Stichwörter der Autor:innen

Leishmaniaacidocalcisomeseugenollipid dropletsmembrane fluiditymembrane permeabilitymode of action

Substanzen

EugenolAmphotericin BAntiprotozoal AgentsSterols

Autor:innen und Institutionen

  • Pharmacognosy Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 72, B1.72.03, B-1200 Brussels, Belgium.
  • CELL Unit and PICT Imaging Platform, de Duve Institute, Université Catholique de Louvain, Avenue Hippocrate 75, B1.75.05, B-1200 Brussels, Belgium.
  • Cellular and Molecular Pharmacology Unit (FACM), Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium.

ORCID-Profile: Kristelle Hughes, Donatienne Tyteca, Marie-Paule Mingeot-Leclercq, Joëlle Quetin-Leclercq

Förderung

  • Vietnamese Ministry of Education and Training
  • UCL
  • F.S.R-FNRS

Zitieren

APA

Hughes, K., Le, T. B., Van Der Smissen, P., Tyteca, D., Mingeot-Leclercq, M. P., & Quetin-Leclercq, J. (2023). The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations. Molecules, 28(9), 3871. https://doi.org/10.3390/molecules28093871

Vancouver

Hughes K, Le TB, Van Der Smissen P, Tyteca D, Mingeot-Leclercq MP, Quetin-Leclercq J. The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations. Molecules. 2023;28(9):3871. doi:10.3390/molecules28093871

BibTeX
@article{Hughes2023,
  author = {Hughes, Kristelle and Le, Thanh Binh and Van Der Smissen, Patrick and Tyteca, Donatienne and Mingeot-Leclercq, Marie-Paule and Quetin-Leclercq, Joëlle},
  title = {The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {9},
  pages = {3871},
  doi = {10.3390/molecules28093871}
}
Kostenlos starten →